Crossmark

Empagliflozin ameliorates diabetic cardiomyopathy via regulated branched-chain amino acid metabolism and mTOR/p-ULK1 signaling pathway-mediated autophagy

Crossref DOI link: https://doi.org/10.1186/s13098-023-01061-6

Published Online: 2023-05-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Lin

Zhang, Heming

Xie, Xiuzhu

Tie, Ruping

Shang, Xiaolin

Zhao, Qianqian

Xu, Junjie

Jin, Liyuan

Zhang, Jinying

Ye, Ping
Funding

Funding for this research was provided by:

National Natural Science Youth Foundation of China (81900730)
License Information

Text and Data Mining valid from 2023-05-06

Version of Record valid from 2023-05-06
More Information

Article History

Received: 19 March 2023

Accepted: 14 April 2023

First Online: 6 May 2023

Declarations

:

: Procedures involving animals and their care were conducted in conformity with the revised guidelines (Animals Act 1986) and were approved by the Experimental Animal Welfare Ethics Committee of PLA General Hospital (Approval No. SQ2021248).

: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential competing interest.

Document is current

Any future updates will be listed below